This site is intended for health professionals only

Gastroenterology

Cautiously positive review of anti-TNF in Crohn’s
Cautiously positive review of anti-TNF in Crohn’s
MS drug to treat Crohn’s disease
MS drug to treat Crohn’s disease
Warning over indigestion drug spend
Warning over indigestion drug spend
Latest advances in the treatment of metastatic colorectal cancer
Latest advances in the treatment of metastatic colorectal cancer
Novartis set to cut 2,500 jobs
Novartis set to cut 2,500 jobs
European esomeprazole process patent validated
European esomeprazole process patent validated
The latest developments of medication therapy in Crohn’s disease
The latest developments of medication therapy in Crohn’s disease
Drug firms start analgesic-induced constipation trial
Drug firms start analgesic-induced constipation trial
EMEA recommends piroxicam restrictions
EMEA recommends piroxicam restrictions
China suspends tegaserod sales
China suspends tegaserod sales
EU approval for Crohn’s drug
EU approval for Crohn’s drug
Court finds AstraZeneca patients infringed
Court finds AstraZeneca patients infringed
1 … 14 15 16 17 18 19


Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
3
Oral vitamin A could become an alternative to isotretinoin for acne
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Pharmacy workforce: matching staffing resource to service demand 



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×